- Abbey Minogue
- Alec Cutler
- Anant Kumar
- Andrew Lockhart
- Chris Brookman
- Contributor
- Craig Brooke
- David Chaplin
- David Dix
- Dion Hershan
- Drew Meredith
- Duncan Hughes
- Emanuel Datt
- Francyne Mu
- George Lin
- Giselle Roux
- Greg Bright
- HMC Capital
- Invesco
- Ishan Dan
- James Dunn
- Jamie Nemtsas
- Jasmine Yeo
- Joanne Driscoll
- Joe Millward
- John Taylor
- Jonathan Pullin
- Jonathan Ruffer
- Joss Engebretsen
- Kevin Toohey
- Lachlan Buur-Jensen
- Lachlan Maddock
- Lauren Ryan
- Laurence Parker-Brown
- Lisa Uhlman
- Matthew O'Leary
- Michael Armitage
- Michael Block
- Mishan Dahia
- Neuberger Berman
- Nicholas Way
- Nick Hatzis
- Nick Langley
- Nicki Bourlioufas
- Owen Raszkiewicz
- Penny Pryor
- Peter McPhee
- Peter Vala
- Phil Strano
- Rob Perrone, Eric Marais & Shane Woldendorp
- Rob Prugue
- Roy Keenan
- Sandy Kaul
- Sophie Bannerman
- Staff Writer
- Tahn Sharpe
- The Inside Adviser
- Tom King
- Tom Patrick
- Tyndall Asset Management Australian Small Companies Team
- Will Arnost
- Yarra Capital Management
Financial Planner's morning report - risk on, gold down, more clarity on Victoria's state of disaster
Risk on, gold down, more clarity on Victoria’s state of disaster The ASX 200 (ASX:XJO) followed a global lead higher, adding close to 200 points to...
Look to Your Own Devices: Biotech Stars of the ASX
In the first of a series on Australian biotech success stories, we start with some of the outstanding medical device stocks on the ASX.
Financial Planner's morning report - state of Disaster, banks under pressure, but a positive start ahead for the ASX
The ASX 200 (XJO:ASX) managed to fight off the widespread implications of Victoria's 'State of Disaster' announcement, finishing flat for the delay despite...
Financial Planner's morning ASX report - ASX down -2.0%, value is dead, long live the FAANG's
The ASX 200 (XJO:ASX) fell 2.0% on Friday, but managed to hold onto a 0.5% gain for the month; it's fourth straight winning month.
ASX 200 set to fall Monday; 3 things investors need to know Monday
The Australian share market and ASX200 (ASX: XJO) finished the week down 0.2%, with the renewed confidence following the extension of the JobKeeper program...
Financial Planner's morning report - Friday
Treasurer Frydenberg provided his long-awaited budget update, which was just that an update, offering little in the way of guidance into the future. The...
Financial Planner's morning report - Thursday
The ASX 200 (ASX:XJO) finished off its lows for the day, falling 1.3%, as both Victoria and several US states hit record COVID-19 case levels, denting market...
Financial Planner's morning report - Wednesday
Despite an increasing chorus of experts suggesting the technology sector has moved beyond reasonable levels, the rally continues. The ASX 200 (ASX:XJO) added...
Social housing - A potential for good returns while helping those in need
A nascent asset class is emerging on the back of the roll out of the National Disability Insurance Scheme (NDIS). NDIS is a welfare support scheme of the...
Financial Planner's morning report - Tuesday
The ASX 200 (ASX:XJO) continued its recent weakness, falling 0.5% on Monday, as concerns of a secondary outbreak in NSW and escalating deaths in the US hit...
'Walking the walk': Why more investors are attracted to co-investing
Alignment of interest is a concept basic to a great many modes of human behaviour yet in the funds management sector it does not necessarily receive the...
Financial Planner's morning report - Monday
Sideways….a weak opening ahead It was another bumpy, albeit positive, week for markets with the ASX 200 (ASX:XJO) gaining 0.4% on Friday and finishing...
Financial Planner's morning report - Monday
Sideways….a weak opening ahead It was another bumpy, albeit positive, week for markets with the ASX 200 (ASX:XJO) gaining 0.4% on Friday and finishing...
Social Bonds - a growing asset class that's packing a positive punch
The broad ESG framework is experiencing a sea change. In the past, governance and environmental issues sparked investor interest, a paradigm COVID-19 is...